US Stock MarketDetailed Quotes

Agios Pharmaceuticals (AGIO)

Watchlist
  • 26.980
  • -0.230-0.85%
Close May 6 16:00 ET
  • 26.980
  • 0.0000.00%
Post 20:01 ET
1.60BMarket Cap-3.72P/E (TTM)

Agios Pharmaceuticals (AGIO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
137.75%20.75M
48.03%54.03M
86.09%19.97M
43.69%12.88M
44.57%12.46M
6.56%8.73M
36.07%36.5M
51.06%10.73M
21.15%8.96M
28.35%8.62M
Operating revenue
137.75%20.75M
48.03%54.03M
86.09%19.97M
43.69%12.88M
44.57%12.46M
6.56%8.73M
36.07%36.5M
51.06%10.73M
21.15%8.96M
28.35%8.62M
Cost of revenue
21.57%1.32M
52.34%6.35M
49.13%1.88M
114.43%1.68M
13.85%1.7M
73.05%1.09M
44.57%4.17M
115.02%1.26M
23.70%783K
34.93%1.5M
Gross profit
154.25%19.43M
47.47%47.68M
91.00%18.09M
36.91%11.2M
51.03%10.75M
1.04%7.64M
35.05%32.33M
45.31%9.47M
20.91%8.18M
27.05%7.12M
Operating expense
13.29%129.45M
13.48%519.82M
3.84%139.67M
15.39%128.07M
22.02%137.81M
14.69%114.27M
10.26%458.07M
19.25%134.51M
3.09%110.99M
13.73%112.94M
Selling and administrative expenses
16.32%48.3M
14.99%180.28M
-0.17%51.61M
7.10%41.27M
29.08%45.87M
33.90%41.53M
30.76%156.78M
46.43%51.7M
49.24%38.54M
16.86%35.54M
Research and development costs
11.55%81.15M
12.70%339.54M
6.33%88.06M
19.79%86.8M
18.78%91.94M
6.01%72.74M
1.95%301.29M
6.87%82.81M
-11.47%72.46M
12.35%77.4M
Operating profit
-3.18%-110.03M
-10.90%-472.13M
2.77%-121.58M
-13.67%-116.87M
-20.07%-127.06M
-15.81%-106.63M
-8.75%-425.74M
-17.65%-125.04M
-1.90%-102.81M
-12.93%-105.82M
Net non-operating interest income expense
-32.90%10.8M
17.25%56.38M
-31.11%12.41M
2.37%13.37M
78.73%14.51M
80.98%16.09M
44.20%48.08M
108.89%18.02M
55.93%13.06M
-1.62%8.12M
Non-operating interest income
-32.90%10.8M
17.25%56.38M
-31.11%12.41M
2.37%13.37M
78.73%14.51M
80.98%16.09M
44.20%48.08M
108.89%18.02M
55.93%13.06M
-1.62%8.12M
Other net income (expense)
-90.50%119K
-99.82%1.96M
-93.04%113K
-99.99%67K
-66.88%523K
-23.32%1.25M
17,994.52%1.1B
-5.25%1.62M
90,950.67%1.09B
-3.72%1.58M
Special income (charges)
----
--0
--0
--0
----
----
--1.09B
--0
--1.09B
----
-Gain on sale of business
----
--0
--0
--0
----
----
--1.09B
--0
--1.09B
----
Other non- operating income (expenses)
-90.50%119K
-69.85%1.96M
-93.04%113K
-95.94%67K
-66.88%523K
-23.32%1.25M
7.13%6.49M
-5.25%1.62M
37.81%1.65M
-3.72%1.58M
Income before tax
-11.00%-99.11M
-157.63%-413.8M
-3.47%-109.06M
-110.33%-103.43M
-16.54%-112.02M
-9.49%-89.29M
303.92%717.97M
-9.86%-105.4M
1,196.14%1B
-14.69%-96.12M
Income tax
-102.30%-1.02M
88.55%-1.02M
0
44.24M
-8.88M
53.12M
Net income
-11.00%-99.11M
-161.27%-412.78M
-11.93%-108.04M
-110.91%-103.43M
-16.54%-112.02M
-9.49%-89.29M
291.35%673.73M
-0.61%-96.52M
1,137.97%947.92M
-14.69%-96.12M
Net income continuous Operations
-11.00%-99.11M
-161.27%-412.78M
-11.93%-108.04M
-110.91%-103.43M
-16.54%-112.02M
-9.49%-89.29M
291.35%673.73M
-0.61%-96.52M
1,137.97%947.92M
-14.69%-96.12M
Minority interest income
Net income attributable to the parent company
-11.00%-99.11M
-161.27%-412.78M
-11.93%-108.04M
-110.91%-103.43M
-16.54%-112.02M
-9.49%-89.29M
291.35%673.73M
-0.61%-96.52M
1,137.97%947.92M
-14.69%-96.12M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-11.00%-99.11M
-161.27%-412.78M
-11.93%-108.04M
-110.91%-103.43M
-16.54%-112.02M
-9.49%-89.29M
291.35%673.73M
-0.61%-96.52M
1,137.97%947.92M
-14.69%-96.12M
Basic earnings per share
-9.03%-1.69
-160.03%-7.12
-7.56%-1.85
-110.69%-1.78
-14.20%-1.93
-6.90%-1.55
287.36%11.86
0.00%-1.72
1,115.24%16.65
-11.92%-1.69
Diluted earnings per share
-9.03%-1.69
-161.17%-7.12
-6.32%-1.85
-110.97%-1.78
-14.20%-1.93
-6.90%-1.55
283.89%11.64
-1.16%-1.74
1,089.02%16.22
-11.92%-1.69
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 137.75%20.75M48.03%54.03M86.09%19.97M43.69%12.88M44.57%12.46M6.56%8.73M36.07%36.5M51.06%10.73M21.15%8.96M28.35%8.62M
Operating revenue 137.75%20.75M48.03%54.03M86.09%19.97M43.69%12.88M44.57%12.46M6.56%8.73M36.07%36.5M51.06%10.73M21.15%8.96M28.35%8.62M
Cost of revenue 21.57%1.32M52.34%6.35M49.13%1.88M114.43%1.68M13.85%1.7M73.05%1.09M44.57%4.17M115.02%1.26M23.70%783K34.93%1.5M
Gross profit 154.25%19.43M47.47%47.68M91.00%18.09M36.91%11.2M51.03%10.75M1.04%7.64M35.05%32.33M45.31%9.47M20.91%8.18M27.05%7.12M
Operating expense 13.29%129.45M13.48%519.82M3.84%139.67M15.39%128.07M22.02%137.81M14.69%114.27M10.26%458.07M19.25%134.51M3.09%110.99M13.73%112.94M
Selling and administrative expenses 16.32%48.3M14.99%180.28M-0.17%51.61M7.10%41.27M29.08%45.87M33.90%41.53M30.76%156.78M46.43%51.7M49.24%38.54M16.86%35.54M
Research and development costs 11.55%81.15M12.70%339.54M6.33%88.06M19.79%86.8M18.78%91.94M6.01%72.74M1.95%301.29M6.87%82.81M-11.47%72.46M12.35%77.4M
Operating profit -3.18%-110.03M-10.90%-472.13M2.77%-121.58M-13.67%-116.87M-20.07%-127.06M-15.81%-106.63M-8.75%-425.74M-17.65%-125.04M-1.90%-102.81M-12.93%-105.82M
Net non-operating interest income expense -32.90%10.8M17.25%56.38M-31.11%12.41M2.37%13.37M78.73%14.51M80.98%16.09M44.20%48.08M108.89%18.02M55.93%13.06M-1.62%8.12M
Non-operating interest income -32.90%10.8M17.25%56.38M-31.11%12.41M2.37%13.37M78.73%14.51M80.98%16.09M44.20%48.08M108.89%18.02M55.93%13.06M-1.62%8.12M
Other net income (expense) -90.50%119K-99.82%1.96M-93.04%113K-99.99%67K-66.88%523K-23.32%1.25M17,994.52%1.1B-5.25%1.62M90,950.67%1.09B-3.72%1.58M
Special income (charges) ------0--0--0----------1.09B--0--1.09B----
-Gain on sale of business ------0--0--0----------1.09B--0--1.09B----
Other non- operating income (expenses) -90.50%119K-69.85%1.96M-93.04%113K-95.94%67K-66.88%523K-23.32%1.25M7.13%6.49M-5.25%1.62M37.81%1.65M-3.72%1.58M
Income before tax -11.00%-99.11M-157.63%-413.8M-3.47%-109.06M-110.33%-103.43M-16.54%-112.02M-9.49%-89.29M303.92%717.97M-9.86%-105.4M1,196.14%1B-14.69%-96.12M
Income tax -102.30%-1.02M88.55%-1.02M044.24M-8.88M53.12M
Net income -11.00%-99.11M-161.27%-412.78M-11.93%-108.04M-110.91%-103.43M-16.54%-112.02M-9.49%-89.29M291.35%673.73M-0.61%-96.52M1,137.97%947.92M-14.69%-96.12M
Net income continuous Operations -11.00%-99.11M-161.27%-412.78M-11.93%-108.04M-110.91%-103.43M-16.54%-112.02M-9.49%-89.29M291.35%673.73M-0.61%-96.52M1,137.97%947.92M-14.69%-96.12M
Minority interest income
Net income attributable to the parent company -11.00%-99.11M-161.27%-412.78M-11.93%-108.04M-110.91%-103.43M-16.54%-112.02M-9.49%-89.29M291.35%673.73M-0.61%-96.52M1,137.97%947.92M-14.69%-96.12M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -11.00%-99.11M-161.27%-412.78M-11.93%-108.04M-110.91%-103.43M-16.54%-112.02M-9.49%-89.29M291.35%673.73M-0.61%-96.52M1,137.97%947.92M-14.69%-96.12M
Basic earnings per share -9.03%-1.69-160.03%-7.12-7.56%-1.85-110.69%-1.78-14.20%-1.93-6.90%-1.55287.36%11.860.00%-1.721,115.24%16.65-11.92%-1.69
Diluted earnings per share -9.03%-1.69-161.17%-7.12-6.32%-1.85-110.97%-1.78-14.20%-1.93-6.90%-1.55283.89%11.64-1.16%-1.741,089.02%16.22-11.92%-1.69
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th Show More